Lifecore Biomedical Stock Market Value
| LFCR Stock | 7.46 0.15 2.05% |
| Symbol | Lifecore |
Lifecore Biomedical Company Valuation
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Lifecore Biomedical. If investors know Lifecore will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Lifecore Biomedical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 0.13 | Revenue Per Share 4.199 | Quarterly Revenue Growth 0.007 | Return On Assets (0.02) | Return On Equity 0.1729 |
The market value of Lifecore Biomedical is measured differently than its book value, which is the value of Lifecore that is recorded on the company's balance sheet. Investors also form their own opinion of Lifecore Biomedical's value that differs from its market value or its book value, called intrinsic value, which is Lifecore Biomedical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Lifecore Biomedical's market value can be influenced by many factors that don't directly affect Lifecore Biomedical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Lifecore Biomedical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Lifecore Biomedical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Lifecore Biomedical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Lifecore Biomedical 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Lifecore Biomedical's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Lifecore Biomedical.
| 10/26/2024 |
| 11/25/2024 |
If you would invest 0.00 in Lifecore Biomedical on October 26, 2024 and sell it all today you would earn a total of 0.00 from holding Lifecore Biomedical or generate 0.0% return on investment in Lifecore Biomedical over 30 days. Lifecore Biomedical is related to or competes with Shuttle Pharmaceuticals, Catalent, Tilray, Kamada, Cumberland Pharmaceuticals, Ironwood Pharmaceuticals, and Journey Medical. Lifecore Biomedical is entity of United States More
Lifecore Biomedical Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Lifecore Biomedical's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Lifecore Biomedical upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 7.29 | |||
| Information Ratio | 0.0716 | |||
| Maximum Drawdown | 30.9 | |||
| Value At Risk | (6.68) | |||
| Potential Upside | 9.76 |
Lifecore Biomedical Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Lifecore Biomedical's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Lifecore Biomedical's standard deviation. In reality, there are many statistical measures that can use Lifecore Biomedical historical prices to predict the future Lifecore Biomedical's volatility.| Risk Adjusted Performance | 0.0801 | |||
| Jensen Alpha | 0.3835 | |||
| Total Risk Alpha | (0.40) | |||
| Sortino Ratio | 0.0602 | |||
| Treynor Ratio | 0.384 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Lifecore Biomedical's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Lifecore Biomedical Backtested Returns
Lifecore Biomedical appears to be moderately volatile, given 3 months investment horizon. Lifecore Biomedical has Sharpe Ratio of 0.16, which conveys that the firm had a 0.16% return per unit of risk over the last 3 months. By analyzing Lifecore Biomedical's technical indicators, you can evaluate if the expected return of 0.81% is justified by implied risk. Please exercise Lifecore Biomedical's Risk Adjusted Performance of 0.0801, mean deviation of 4.14, and Downside Deviation of 7.29 to check out if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Lifecore Biomedical holds a performance score of 12. The company secures a Beta (Market Risk) of 1.46, which conveys a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Lifecore Biomedical will likely underperform. Please check Lifecore Biomedical's potential upside, and the relationship between the total risk alpha and kurtosis , to make a quick decision on whether Lifecore Biomedical's current price movements will revert.
Auto-correlation | 0.73 |
Good predictability
Lifecore Biomedical has good predictability. Overlapping area represents the amount of predictability between Lifecore Biomedical time series from 26th of October 2024 to 10th of November 2024 and 10th of November 2024 to 25th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Lifecore Biomedical price movement. The serial correlation of 0.73 indicates that around 73.0% of current Lifecore Biomedical price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.73 | |
| Spearman Rank Test | 0.54 | |
| Residual Average | 0.0 | |
| Price Variance | 0.14 |
Lifecore Biomedical lagged returns against current returns
Autocorrelation, which is Lifecore Biomedical stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Lifecore Biomedical's stock expected returns. We can calculate the autocorrelation of Lifecore Biomedical returns to help us make a trade decision. For example, suppose you find that Lifecore Biomedical has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Lifecore Biomedical regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Lifecore Biomedical stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Lifecore Biomedical stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Lifecore Biomedical stock over time.
Current vs Lagged Prices |
| Timeline |
Lifecore Biomedical Lagged Returns
When evaluating Lifecore Biomedical's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Lifecore Biomedical stock have on its future price. Lifecore Biomedical autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Lifecore Biomedical autocorrelation shows the relationship between Lifecore Biomedical stock current value and its past values and can show if there is a momentum factor associated with investing in Lifecore Biomedical.
Regressed Prices |
| Timeline |
Pair Trading with Lifecore Biomedical
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Lifecore Biomedical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lifecore Biomedical will appreciate offsetting losses from the drop in the long position's value.Moving against Lifecore Stock
| 0.8 | JNJ | Johnson Johnson Fiscal Year End 28th of January 2025 | PairCorr |
| 0.79 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
| 0.79 | TCHH | Trustcash Holdings | PairCorr |
| 0.78 | PFE | Pfizer Inc Aggressive Push | PairCorr |
| 0.76 | AGL | agilon health Buyout Trend | PairCorr |
The ability to find closely correlated positions to Lifecore Biomedical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Lifecore Biomedical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Lifecore Biomedical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Lifecore Biomedical to buy it.
The correlation of Lifecore Biomedical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Lifecore Biomedical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Lifecore Biomedical moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Lifecore Biomedical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Lifecore Stock Analysis
When running Lifecore Biomedical's price analysis, check to measure Lifecore Biomedical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lifecore Biomedical is operating at the current time. Most of Lifecore Biomedical's value examination focuses on studying past and present price action to predict the probability of Lifecore Biomedical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lifecore Biomedical's price. Additionally, you may evaluate how the addition of Lifecore Biomedical to your portfolios can decrease your overall portfolio volatility.